Quick facts
- An automated blood grouping and antibody test system groups red cells and detects antibodies to blood group antigens — the ABO and Rh typing and the antibody screen that stand behind a decision to transfuse.
- In the United States it files under 21 CFR 864.9175, Automated blood grouping and antibody test system, at Class II (performance standards), product code KSZ.
- Canada classes it as an in vitro diagnostic device. Part 2 Rule 5 of Schedule 1 places an IVDD used for blood grouping or tissue typing to ensure immunological compatibility of blood intended for transfusion at Class III.
- Rule 5 is written for the purpose of the test, not for the instrument: a manual tube method and an automated analyser running the same typing are both Class III in Canada.
- Rule 7 then pairs any analyser with the IVDD it is used with, so an instrument also run with a donor-screening assay classified under Rule 1 takes Class IV for that use.
- Entries, classes, product codes and rule text below were checked against the eCFR, the consolidated Regulations and the openFDA classification database on 2026-10-14.
Blood grouping is the laboratory step that decides whether a unit of blood can be given to a patient: forward and reverse ABO typing, Rh typing, an antibody screen and, where the screen is positive, a crossmatch. An automated blood grouping and antibody test system performs those steps at scale, and its two regulatory homes could not be more differently built. The United States names the instrument in a single Class II entry. Canada classes it by what the test is for, and the rule that reaches blood grouping for transfusion is a Class III rule. This article sets out both routes and the records a transfusion service keeps, with the graduated specimen containers that carry the samples to the bench.
What is an automated blood grouping and antibody test system?
It is a device used to group erythrocytes and to detect antibodies to blood group antigens. In the transfusion service it runs the front end of the compatibility chain: the red cell phenotype and the ABO/Rh group of the patient and of the unit, the antibody screen that looks for unexpected antibodies, and the crossmatch that confirms the pairing before a unit leaves the blood bank. The result is not a general diagnostic read-out; it is the information on which a transfusion decision is made.
That framing is what makes the class question interesting. The same instrument, running the same chemistry, is filed in one country by a numeric entry and in the other by a rule that was written around the immunological compatibility of blood intended for transfusion. The instrument on the bench and the reagent it is run with are both regulated articles, and they travel together.
Is an automated blood grouping system a Class II device in the United States?
Yes. 21 CFR 864.9175 is titled Automated blood grouping and antibody test system and the identification reads: \"An automated blood grouping and antibody test system is a device used to group erythrocytes (red blood cells) and to detect antibodies to blood group antigens.\" The entry sits at Class II (performance standards).
The openFDA device classification API lists three product codes under that regulation number: KSZ for the automated system, PBC for manual blood grouping and antibody test systems, and OQX for a self-contained grouping device. The point of the entry is that the class attaches to the grouping and antibody-detection function rather than to the degree of automation, so a bench that moves from a manual tube method to an analyser stays inside the same regulation number.
| Item | Detail |
|---|---|
| US regulation | 21 CFR 864.9175 - Automated blood grouping and antibody test system |
| US class | Class II (performance standards) |
| Product codes | KSZ (automated system), PBC (manual system), OQX (self-contained device) |
| Route to market | Premarket notification with the performance standard applied |
| What it produces | Red cell grouping and detection of antibodies to blood group antigens |
| Where it is run | A transfusion service laboratory, on patient and unit samples |
How does Canada classify a blood grouping system?
Canada treats the test as an in vitro diagnostic device — a medical device intended to be used in vitro for the examination of specimens taken from the body — and applies Part 2 of Schedule 1 of the Medical Devices Regulations. The governing rule is Part 2 Rule 5, and it is short: \"An IVDD that is intended to be used for blood grouping or tissue typing to ensure the immunological compatibility of blood, blood components, tissue or organs that are intended for transfusion or transplantation is classified as Class III.\" The class is Class III.
Two things about that rule matter to a buyer. First, it is written around the purpose of the test, not around the instrument: an automated analyser and a manual tube method used for the same typing both sit at Class III, which is why the US entry's three product codes collapse into one Canadian answer. Second, it is a different rule from the one that reaches a transmissible-agent assay. Part 2 Rule 1 covers an IVDD used to detect a transmissible agent in blood to assess its suitability for transfusion, and places it at Class IV; Rule 2 covers a diagnostic assay for a transmissible agent and starts at Class II with listed lifts. A grouping system detects antigens and antibodies, not an infectious agent, so Rule 5 is the rule that fits it rather than Rules 1 or 2.
| Item | Canada | United States |
|---|---|---|
| Named entry | None; classified by rule | 864.9175, Class II |
| Class | Class III (Part 2, Rule 5) | Class II (performance standards) |
| Governing text | Schedule 1, Part 2, Rule 5 | 21 CFR 864.9175 |
| Rule 1 or Rule 2 instead? | No; those reach transmissible-agent assays in blood | Not applicable |
| Route to market | Device licence (Class III) with quality-system and performance evidence | Premarket notification with the performance standard |
Does the instrument change class with the test it is run with?
Yes, in Canada it can, and this is the part of the rulebook that a transfusion service is most likely to meet in practice. Part 2 Rule 7 states that where an IVDD, including its analyzers, reagents and software, is intended to be used with another IVDD, the class of both IVDDs is that of the IVDD in the class representing the higher risk. The analyzer is therefore not permanently one class; it takes the class of the highest-class IVDD it is used with.
The practical consequence is visible in a blood bank that runs donor screening on the same platform as patient grouping. A donor-screening assay is classified under Rule 1 and takes Class IV. If the analyser is intended to be used with that assay, Rule 7 gives both articles the higher class for that use. That is why the intended-use statement on the analyser and the assay menu it is validated for are the documents a purchaser should read together.
| Use on the label | Class, Canada | Class, US |
|---|---|---|
| Group red cells and detect antibodies to blood group antigens | III (Part 2, Rule 5) | II (864.9175) |
| Tissue typing for immunological compatibility | III (Part 2, Rule 5) | II (864.9175 range) |
| Screen donors for a transmissible agent in blood | IV (Part 2, Rule 1) | Separate donor-screening regime |
| Analyzer shared with a higher-class IVDD | Takes the higher class (Part 2, Rule 7) | Unchanged by the reagent |
There is a second near miss worth naming, because it is the rule a reader reaches for first. Part 2 Rule 3 covers an IVDD used for patient management and places it at Class II unless the test manages a life-threatening disease or an erroneous result would lead to a management decision creating an imminent life-threatening situation. A grouping system would be caught by that subrule as well, and would land at Class III on either limb. Rule 5 is quoted here because it is the rule written for this exact use, and because a rule that names blood grouping is the cleaner authority to cite on an order record.
What should a transfusion service check before ordering?
Four checks. First, confirm the intended use on the labelling of the analyser and of each reagent line, because in Canada the class travels with the highest-class IVDD the instrument is used with. Second, confirm the assay menu the analyser is validated for, including the antibody screen and any phenotyping panel, since a menu that is extended after installation can change the regulatory position of the platform. Third, confirm the calibration, control and traceability documentation the maker states, because a grouping result is only defensible with its control performance recorded. Fourth, confirm the sample-handling and labelling conditions in the maker's instructions, since a specimen that arrives in the wrong tube is a pre-analytical error the analyser cannot detect.
A transfusion service also reorders the specimen-handling and PPE lines that sit on the same bench. Clinics that stock for a whole practice can order through the wholesale programme and request a bulk quote for a standing or annual order; the graduated specimen containers sits in the same catalogue. Consumables for this line are listed under diagnostic laboratories. Reselling? become a distributor.
How does the class affect the records a blood bank keeps?
The class sets the market-entry path; the record is set by the method. A grouping or antibody screen is recorded with the sample identity, the reagent lot and the control results, the platform and software version, the reader, the date and time, and the interpretation. Where the result is unexpected, the record also carries the repeat and the reference-method confirmation and the action taken before any unit was released.
Because the service holds both patient and unit samples, the routine also includes the handling and storage conditions the maker states, the retention period the service applies to transfusion records and the traceability that links each unit to the patient who received it. None of that changes with the class; it is the ordinary routine of a transfusion service, and the record is what shows the instrument and the reagents were used as the maker intended.
Sources
- openFDA device classification API
- Medical Devices Regulations, SOR/98-282, full text and Schedule 1
- US FDA, medical device databases
- US FDA, overview of device regulation
- Health Canada, medical devices
- Health Canada, establishment licensing
- Clinical and Laboratory Standards Institute
- Public Health Ontario, infection prevention and control
- ISO 15189:2022, medical laboratories, requirements for quality and competence
- ISO 13485:2016, medical devices quality management
- ISO 14971:2019, application of risk management to medical devices
- ISO 17511:2020, metrological traceability of values assigned to calibrators
- World Health Organization
- Standards Council of Canada
- CSA Group
- CCOHS, OSH answers
- Health Canada, medical device licence application guidance
One sheet per bench, printed and dated. A grouping or antibody screen has to show its reagent lot, its control result and who read it, and the compliance log centre carries a blank reagent-and-control sheet you can print for the bench — open the downloadable pack. No account and no sign-up, and the service can print as many copies as it runs working days.
Set the bench up once. Type the facility name, the bench and the test menu once, and the sterilization log generator lays out dated control and equipment lines you can print or file into the quality manual.
Ask a compliance specialist. A classification question usually turns on how the device is used, not only on its name. Ask a compliance specialist — you get a written answer specific to your equipment and province, with the regulation or standard it is based on cited.
Related reading
- Hematocrit tubes and readers in Canada vs the US
- Platelet aggregometers in Canada vs the US
- ESR tubes in Canada vs the US
CliniEco Medical supplies eye care, laboratory and dental consumables of the kind described in this article. MDEL #35334. This article is written for optometry, laboratory and dental procurement professionals and is not legal advice; the class of a device and the records a practice keeps belong to the manufacturer and to the requirements that apply to it.
Frequently Asked Questions
What class is an automated blood grouping and antibody test system in the United States?
Class II (performance standards), under 21 CFR 864.9175, with product code KSZ for the automated system and PBC for manual systems.
What class is it in Canada?
Class III. Part 2 Rule 5 of Schedule 1 of the Medical Devices Regulations places an IVDD used for blood grouping or tissue typing to ensure immunological compatibility of blood intended for transfusion at Class III.
Does automation change the Canadian class?
No. Rule 5 is written around the purpose of the test, so a manual tube method and an automated analyser used for the same typing are both Class III.
Can the analyser take a different class?
Yes. Part 2 Rule 7 provides that where an IVDD, including its analyzers, reagents and software, is intended to be used with another IVDD, both take the class of the higher-risk IVDD. An analyser also run with a Class IV donor-screening assay takes that class for the use.
Is a grouping system caught by the transmissible-agent rules?
No. Part 2 Rule 1 reaches an IVDD used to detect a transmissible agent in blood to assess its suitability for transfusion, and Rule 2 reaches diagnostic assays for transmissible agents. A grouping system detects red cell antigens and antibodies, so Rule 5 applies.
What else is an automated blood grouping system called?
It is also written as blood bank analyser, immunohematology analyser, type and screen system, and pre-transfusion testing platform; the US regulation describes the same article as a device used to group erythrocytes and detect antibodies to blood group antigens.
0 comments